4.6 Article

Factors associated with poor quality of life among cervical cancer survivors: Implications for clinical care and clinical trials

期刊

GYNECOLOGIC ONCOLOGY
卷 135, 期 2, 页码 266-272

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2014.08.036

关键词

Cervical cancer; Patient-reported outcomes; Symptoms; Clinical trial

资金

  1. National Cancer Institute [RO1 CA118136-01, P30CA062203-18S3]

向作者/读者索取更多资源

Introduction. The purpose of this study is to identify factors that are associated with poor quality of life (QOL) among cervical cancer survivors. Methods. Patients identified through the California Cancer Registry were recruited to participate in a randomized counseling intervention. Patient-reported outcomes (PROs) were collected at study baseline (9-30 months post-diagnosis) and subsequent to the intervention. Multivariable linear models were used to identify independent factors associated with poor baseline QOL. Results. Non-Hispanic (N = 121) and Hispanic (N = 83) women aged 22-73 completed baseline measures. Approximately 50% of participants received radiation therapy with or without chemotherapy. Compared to the US population, cervical cancer patients reported lower QOL and significantly higher levels of depression and anxiety (26% and 28% > 1 SD above the general population means, respectively). Among those in the lowest quartile for QOL, 63% had depression levels > 1 SD above the mean. In addition, treatment with radiation chemotherapy (p = 0.014), and self-reported comorbidities predating the cancer diagnosis (p < 0.001) were associated with lower QOL. Sociodemographic characteristics explained only a small portion of variance in QOL (r(2) = 0.23). Persistent gynecologic problems, low social support, depression, somatization, less adaptive coping, comorbidities, sleep problems and low education were all independently associated with low QOL in multivariate analysis (r(2) = 0.74). Conclusion. We have identified key psychological and physical health factors that contribute significantly to poor quality of life subsequent to definitive cancer treatment. The majority of these factors are amenable to supportive care interventions and should be evaluated at the time of primary treatment. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据